Skip to main content
Erschienen in: Annals of Hematology 10/2015

01.10.2015 | Original Article

Recruitment of CD8+ T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1+ in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation

verfasst von: Xiao-Hui Zhang, Guo-Xiang Wang, Hong-Hu Zhu, Yan-Rong Liu, Lan-Ping Xu, Wei Han, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Jing-Zhi Wang, Yu Wang, Ting Zhao, Yao Chen, Ru Feng, Hai-Xia Fu, Min Wang, Yi Zhou, Meng Lv, Kai-Yan Liu, Xiao-Jun Huang

Erschienen in: Annals of Hematology | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Prolonged isolated thrombocytopenia is a common complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT), which is associated with a poor prognosis. This study aimed to investigate the pathogenesis of prolonged isolated thrombocytopenia (PT). We analysed the expression of CX3CR1 on CD4 and CD8 T cells in bone marrow (BM) and peripheral blood (PB) at +90 days from allo-HSCT recipients with or without PT by flow cytometry analyses. We then determined the megakaryocytes ploidy distributions, apoptosis rate and Fas expression of recipients with or without PT in vitro directly or after depleting CD8+ T cells or adding purified autologous CD8+ T cells to CD8+ T-dep MNCs. We found that the percentage of CD8+ T cells in BM was higher in the patients with PT than in the controls. The elevated expression of the CX3CR1 was associated with PT. There was a marked increase in the percentage of low ploidy megakaryocytes in the recipients with PT. The depletion of CD8+ T cells increased the apoptosis of megakaryocytes and decreased the expression of Fas, which could be corrected by re-adding purified autologous CD8+ T cells. The increase of CD8+ T cells and CD8+/CX3CR1+ T cells in BM at +90 days were independent risk factors for PT according to multivariate analysis. Our data implied that the recruitment of CD8+ T cells into BM might explain the suppression of megakaryocyte apoptosis through the elevated expression of CX3CR1+ in PT after allo-HSCT. CX3CR1 might be a novel treatment target in recipients with PT.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Zhang X et al (2011) Prolonged thrombocytopenia following allogeneic hematopoietic stem cell transplantation and its association with a reduction in ploidy and an immaturation of megakaryocytes. Biol Blood Marrow Transplant 17(2):274–280CrossRefPubMed Zhang X et al (2011) Prolonged thrombocytopenia following allogeneic hematopoietic stem cell transplantation and its association with a reduction in ploidy and an immaturation of megakaryocytes. Biol Blood Marrow Transplant 17(2):274–280CrossRefPubMed
2.
Zurück zum Zitat Yamazaki R et al (2006) Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant 38(5):377–384CrossRefPubMed Yamazaki R et al (2006) Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant 38(5):377–384CrossRefPubMed
3.
Zurück zum Zitat Kong Y et al (2014) Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20(8):1190–1197CrossRefPubMed Kong Y et al (2014) Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20(8):1190–1197CrossRefPubMed
4.
Zurück zum Zitat Kim DH et al (2006) Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with severe acute GVHD. Bone Marrow Transplant 37(1):101–108PubMed Kim DH et al (2006) Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with severe acute GVHD. Bone Marrow Transplant 37(1):101–108PubMed
5.
Zurück zum Zitat Poon LM et al (2013) Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation. Am J Blood Res 3(3):260–264PubMedCentralPubMed Poon LM et al (2013) Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation. Am J Blood Res 3(3):260–264PubMedCentralPubMed
6.
Zurück zum Zitat Shono Y et al (2014) Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20(4):495–500CrossRefPubMed Shono Y et al (2014) Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20(4):495–500CrossRefPubMed
7.
Zurück zum Zitat Pihusch R et al (2002) Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation 74(9):1303–1309CrossRefPubMed Pihusch R et al (2002) Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation 74(9):1303–1309CrossRefPubMed
8.
Zurück zum Zitat Nash RA et al (1996) The problem of thrombocytopenia after hematopoietic stem cell transplantation. Stem Cells 14(Suppl 1):261–273CrossRefPubMed Nash RA et al (1996) The problem of thrombocytopenia after hematopoietic stem cell transplantation. Stem Cells 14(Suppl 1):261–273CrossRefPubMed
9.
Zurück zum Zitat Nakamae H et al (2011) Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs. Haematologica 96(12):1838–1845PubMedCentralCrossRefPubMed Nakamae H et al (2011) Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs. Haematologica 96(12):1838–1845PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Ronghe MD et al (2002) The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation. Br J Haematol 118(4):1124–1127CrossRefPubMed Ronghe MD et al (2002) The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation. Br J Haematol 118(4):1124–1127CrossRefPubMed
11.
Zurück zum Zitat Bruno B et al (2001) Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7(3):154–162CrossRefPubMed Bruno B et al (2001) Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7(3):154–162CrossRefPubMed
12.
Zurück zum Zitat Reid R et al (2012) Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia. Am J Hematol 87(7):743–745CrossRefPubMed Reid R et al (2012) Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia. Am J Hematol 87(7):743–745CrossRefPubMed
13.
Zurück zum Zitat Mattia G et al (2002) Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 99(3):888–897CrossRefPubMed Mattia G et al (2002) Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 99(3):888–897CrossRefPubMed
14.
15.
Zurück zum Zitat De Botton S et al (2002) Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 100(4):1310–1317CrossRefPubMed De Botton S et al (2002) Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 100(4):1310–1317CrossRefPubMed
16.
Zurück zum Zitat Li S et al (2007) CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura. Br J Haematol 139(4):605–611CrossRefPubMed Li S et al (2007) CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura. Br J Haematol 139(4):605–611CrossRefPubMed
17.
Zurück zum Zitat Houwerzijl EJ et al (2006) Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death. Leukemia 20(11):1937–1942CrossRefPubMed Houwerzijl EJ et al (2006) Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death. Leukemia 20(11):1937–1942CrossRefPubMed
18.
Zurück zum Zitat Olsson B et al (2008) Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1. Blood 112(4):1078–1084CrossRefPubMed Olsson B et al (2008) Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1. Blood 112(4):1078–1084CrossRefPubMed
19.
Zurück zum Zitat Brissot E et al (2015) Involvement of the CX3CL1 (fractalkine)/CX3CR1 pathway in the pathogenesis of acute graft-versus-host disease. J Leukoc Biol 97(2):227–235CrossRefPubMed Brissot E et al (2015) Involvement of the CX3CL1 (fractalkine)/CX3CR1 pathway in the pathogenesis of acute graft-versus-host disease. J Leukoc Biol 97(2):227–235CrossRefPubMed
20.
Zurück zum Zitat Zhang Y et al (2005) Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J Immunol 174(5):3051–3058CrossRefPubMed Zhang Y et al (2005) Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J Immunol 174(5):3051–3058CrossRefPubMed
21.
Zurück zum Zitat Imai T et al (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91(4):521–530CrossRefPubMed Imai T et al (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91(4):521–530CrossRefPubMed
22.
Zurück zum Zitat Wang Y et al (2013) Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer 119(5):978–985CrossRefPubMed Wang Y et al (2013) Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer 119(5):978–985CrossRefPubMed
23.
Zurück zum Zitat Chang YJ, Huang XJ (2014) Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers. Bone Marrow Transplant 49(7):873–879CrossRefPubMed Chang YJ, Huang XJ (2014) Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers. Bone Marrow Transplant 49(7):873–879CrossRefPubMed
24.
Zurück zum Zitat Tomer A (2004) Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes. Blood 104(9):2722–2727CrossRefPubMed Tomer A (2004) Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes. Blood 104(9):2722–2727CrossRefPubMed
25.
Zurück zum Zitat Mick R, Williams SF, Bitran JD (1990) Patients at increased risk for late engraftment after transplantation: a novel method for their identification. Bone Marrow Transplant 6(3):185–191PubMed Mick R, Williams SF, Bitran JD (1990) Patients at increased risk for late engraftment after transplantation: a novel method for their identification. Bone Marrow Transplant 6(3):185–191PubMed
26.
Zurück zum Zitat Anasetti C et al (1989) Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood 73(4):1054–1058PubMed Anasetti C et al (1989) Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood 73(4):1054–1058PubMed
27.
Zurück zum Zitat Sivakumaran M et al (1995) Thrombocytopenia following autologous bone marrow transplantation: evidence for autoimmune aetiology and B cell clonal involvement. Bone Marrow Transplant 15(4):531–536PubMed Sivakumaran M et al (1995) Thrombocytopenia following autologous bone marrow transplantation: evidence for autoimmune aetiology and B cell clonal involvement. Bone Marrow Transplant 15(4):531–536PubMed
28.
Zurück zum Zitat Kim DH et al (2006) Clinical significance of platelet count at day +60 after allogeneic peripheral blood stem cell transplantation. J Korean Med Sci 21(1):46–51PubMedCentralCrossRefPubMed Kim DH et al (2006) Clinical significance of platelet count at day +60 after allogeneic peripheral blood stem cell transplantation. J Korean Med Sci 21(1):46–51PubMedCentralCrossRefPubMed
29.
Zurück zum Zitat Bolwell B et al (2004) Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplant 33(4):419–423CrossRefPubMed Bolwell B et al (2004) Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplant 33(4):419–423CrossRefPubMed
30.
Zurück zum Zitat Umehara H et al (2004) Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 24(1):34–40CrossRefPubMed Umehara H et al (2004) Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 24(1):34–40CrossRefPubMed
31.
Zurück zum Zitat Yoneda O et al (2000) Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 164(8):4055–4062CrossRefPubMed Yoneda O et al (2000) Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 164(8):4055–4062CrossRefPubMed
32.
Zurück zum Zitat Di Rosa F, Pabst R (2005) The bone marrow: a nest for migratory memory T cells. Trends Immunol 26(7):360–366CrossRefPubMed Di Rosa F, Pabst R (2005) The bone marrow: a nest for migratory memory T cells. Trends Immunol 26(7):360–366CrossRefPubMed
33.
Zurück zum Zitat Tomer A et al (1989) Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts. Blood 74(2):594–601PubMed Tomer A et al (1989) Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts. Blood 74(2):594–601PubMed
34.
Zurück zum Zitat Falcieri E et al (2000) Ultrastructural characterization of maturation, platelet release, and senescence of human cultured megakaryocytes. Anat Rec 258(1):90–99CrossRefPubMed Falcieri E et al (2000) Ultrastructural characterization of maturation, platelet release, and senescence of human cultured megakaryocytes. Anat Rec 258(1):90–99CrossRefPubMed
35.
Zurück zum Zitat White MJ, Kile BT (2010) Apoptotic processes in megakaryocytes and platelets. Semin Hematol 47(3):227–234CrossRefPubMed White MJ, Kile BT (2010) Apoptotic processes in megakaryocytes and platelets. Semin Hematol 47(3):227–234CrossRefPubMed
36.
Zurück zum Zitat Spencer A, Jackson J, Baulch-Brown C (2001) Enumeration of bone marrow ‘homing’ haemopoietic stem cells from G-CSF-mobilised normal donors and influence on engraftment following allogeneic transplantation. Bone Marrow Transplant 28(11):1019–1022CrossRefPubMed Spencer A, Jackson J, Baulch-Brown C (2001) Enumeration of bone marrow ‘homing’ haemopoietic stem cells from G-CSF-mobilised normal donors and influence on engraftment following allogeneic transplantation. Bone Marrow Transplant 28(11):1019–1022CrossRefPubMed
37.
Zurück zum Zitat Italiano JE Jr, Shivdasani RA (2003) Megakaryocytes and beyond: the birth of platelets. J Thromb Haemost 1(6):1174–1182CrossRefPubMed Italiano JE Jr, Shivdasani RA (2003) Megakaryocytes and beyond: the birth of platelets. J Thromb Haemost 1(6):1174–1182CrossRefPubMed
Metadaten
Titel
Recruitment of CD8+ T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1+ in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation
verfasst von
Xiao-Hui Zhang
Guo-Xiang Wang
Hong-Hu Zhu
Yan-Rong Liu
Lan-Ping Xu
Wei Han
Huan Chen
Yu-Hong Chen
Feng-Rong Wang
Jing-Zhi Wang
Yu Wang
Ting Zhao
Yao Chen
Ru Feng
Hai-Xia Fu
Min Wang
Yi Zhou
Meng Lv
Kai-Yan Liu
Xiao-Jun Huang
Publikationsdatum
01.10.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 10/2015
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-015-2436-6

Weitere Artikel der Ausgabe 10/2015

Annals of Hematology 10/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.